NCT04219254 2026-02-25
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
BioInvent International AB
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT05307874 2025-12-24
EVICTION-2
ImCheck Therapeutics
Phase 1/2 Completed
NCT04585035 2025-03-18
Study to Evaluate D-1553 in Subjects With Solid Tumors
InventisBio Co., Ltd
Phase 1/2 Active not recruiting
NCT05763004 2024-10-08
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
ImmunOs Therapeutics AG
Phase 1 Unknown
NCT06462794 2024-09-19
First In Human Study of CX-801 in Advanced Solid Tumors
CytomX Therapeutics
Phase 1 Recruiting
NCT03274661 2023-10-19
Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors
Baptist Health South Florida
Phase 2 Completed